Business ❯ Corporate Governance ❯ Shareholder Rights ❯ Securities Regulation

False Statements

Skye Bioscience Investors Face Jan. 16 Lead-Plaintiff Deadline in Lawsuit Over Nimacimab Claims

Shareholders are not represented unless they retain counsel at this stage.

DeFi Technologies Faces Securities Class Action in New York as Law Firms Seek Lead Plaintiffs